Pizotifen

苯噻啶

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePizotifen
Drug Alias Name苯塞啶pizotifenumpizotifeno苯唆陡Pizotylline +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor antagonists
TargetsSerotonin (5-HT) receptor
Therapy Area/IndicationsChronic UrticariaAngioedemaVentricular Premature Complexes +[6] 
Global Approved IndicationsChronic UrticariaAngioedemaVentricular Premature Complexes +[6] 
Approved Indications in ChinaChronic UrticariaAngioedemaVentricular Premature Complexes +[5] 
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1974/03/15
Country/TerritoryCanadaBangladeshUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesPaladin Labs IncBangabandhu Sheikh Mujib Medical UniversityPhoenix Labs Inc +[4] 
Inactive CompaniesN/A
Active IndicationsChronic UrticariaAngioedemaVentricular Premature Complexes +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN02CX01
Related LinksWikipediaKEGG